共 530 条
[31]
Penack O(2006)Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies Bone Marrow Transplant 38 291-784
[32]
Marchetti M(2009)Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation Biol Blood Marrow Transplant 15 257-660
[33]
Ruutu T(2020)Prognostic factors and long-term follow-up of basiliximab for steroid-refractory acute graft-versus-host disease: updated experience from a large-scale study Am J Hematol 95 927-408
[34]
Aljurf M(2015)National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report Biol Blood Marrow Transplant 21 389-85
[35]
Bacigalupo A(2009)Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement Biol Blood Marrow Transplant 15 777-295
[36]
Bonifazi F(2018)Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: prospective single-center study J Clin Apher 33 654-61
[37]
Ciceri F(2006)The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease Haematologica 91 405-685
[38]
Cornelissen J(2006)Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease Int J Hematol 83 80-837
[39]
Malladi R(2002)Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients Bone Marrow Transplant 30 287-1422
[40]
Duarte RF(2004)Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant Eur J Haematol 73 56-965